MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by nemo3on Jul 03, 2020 10:39am

171 Views

Post# 31220371

RE:MIR SP

I guess if you look at MIR having over 10 times the OS of SONA, then we could say if MIR was also at the same amount of OS of SONA, then MIR would be trading at about $4.20. Upon FDA approval, one would expect MIR to shoot higher but I would think more like the $1 or $2 level... again base on OS. But just my opinion.......nothing more.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading